GetTopicDetailResponse(id=5746150e104, topicName=RAD51, introduction=RAD51, content=null, image=null, comments=4, allHits=1228, url=https://h5.medsci.cn/topic?id=15071, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=5070, tagList=[TagDto(tagId=5070, tagName=RAD51)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1655626, encodeId=5bb316556269f, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, objectTitle=AACR重磅之PETRA試驗：新一代PARP1選擇性抑制劑AZD5305在BRCA1/2、PALB2或RAD51C/D突變的患者（pts）中的首次人體試驗, objectType=article, longId=723981, objectId=f235e2398163, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f235e2398163, replyNumber=0, likeNumber=55, createdTime=2022-07-08, rootId=0, userName=syscxl, userId=0fd024763623, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f235e2398163, moduleTitle=AACR重磅之PETRA試驗：新一代PARP1選擇性抑制劑AZD5305在BRCA1/2、PALB2或RAD51C/D突變的患者（pts）中的首次人體試驗, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=f235e2398163)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655625, encodeId=0cd5165562513, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, objectTitle=Cell Death Differ：PARP1、MRE11和RAD51共同影響結(jié)直腸癌腫瘤干細胞的DNA復制應激和有絲分裂, objectType=article, longId=206760, objectId=b803206e60e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b803206e60e1, replyNumber=0, likeNumber=86, createdTime=2021-12-13, rootId=0, userName=syscxl, userId=0fd024763623, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b803206e60e1, moduleTitle=Cell Death Differ：PARP1、MRE11和RAD51共同影響結(jié)直腸癌腫瘤干細胞的DNA復制應激和有絲分裂, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b803206e60e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655623, encodeId=8771165562349, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, objectTitle=Cancer Cell：FA基因與RAD51-BRCA1/2聯(lián)合保護DNA復制叉，抑制腫瘤發(fā)生, objectType=article, longId=7871, objectId=5a9de8719e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a9de8719e, replyNumber=0, likeNumber=0, createdTime=2013-06-27, rootId=0, userName=syscxl, userId=0fd024763623, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a9de8719e, moduleTitle=Cancer Cell：FA基因與RAD51-BRCA1/2聯(lián)合保護DNA復制叉，抑制腫瘤發(fā)生, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=5a9de8719e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1655624, encodeId=03ba1655624fa, content=<a href='/topic/show?id=5746150e104' target=_blank style='color:#2F92EE;'>#RAD51#</a>, objectTitle=Nature Genet：男性乳腺癌與RAD51B基因變異有關, objectType=article, longId=9934, objectId=c9e99934d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c9e99934d9, replyNumber=0, likeNumber=80, createdTime=2013-02-15, rootId=0, userName=syscxl, userId=0fd024763623, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c9e99934d9, moduleTitle=Nature Genet：男性乳腺癌與RAD51B基因變異有關, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c9e99934d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
